Bladder Pain Syndrome – An Evolution: Edition 2

Philip M. Hanno · Jørgen Nordling · David R. Staskin · Alan J. Wein · Jean Jacques Wyndaele

Oct 2017 · Springer

About this ebook

Until recently interstitial cystitis was considered a urologic curiosity, a rare problem with relatively specific diagnostic criteria that many urologists would see only once or twice in a decade. This has changed drastically in the last ten years. Interstitial cystitis is now a very controversial subject that has ignited the interest of physicians in general, urologists in particular, basic scientists and even government agencies. It is a potentially much more common and more devastating disorder (or group of disorders) than had been believed. The exponential growth in clinical and basic research is largely due to the efforts of patient groups who demanded that more attention be paid to this problem. We owe them a debt of gratitude for putting interstitial cystitis in the spotlight and quite literally under the microscope. In this book we have attempted to put together the current views of experts from around the world regarding the many aspects of this disorder. It is hoped that we can provide an image of where we stand as we enter the 1990s. If the book can stimulate other physicians and basic scientists to enter this exciting field of research, and if it can provide hope to the many thousands of patients who suffer from this disease, we will consider it a success. Acknowledgement This book is dedicated to the Interstitial Cystitis Association and its hundreds of members who have contributed so much of their time and effort toward making this disease less of a mystery.

About the author

Philip M. Hanno, MD, MPH, has a long-standing interest in bladder pain syndrome and female urology, and is Co-Chair of the Medical Advisory Board of the Interstitial Cystitis Association. He is chair of the American Urological Association Guideline Committee on Interstitial Cystitis. He has been Chief of the Division of Urology of the Philadelphia Veterans Administration Medical Center and Professor and Chair of the Department of Urology at Temple University School of Medicine. He was a Medical Officer in the Division of Reproductive and Urologic Drugs in the Food and Drug Administration. He is currently an Emeritus Professor of Urology at the University of Pennsylvania and is Clinical Professor of Urology at Stanford University School of Medicine.

Alan J. Wein, MD, PhD(hon.), FACS Alan J. Wein, MD, PhD(hon.), FACS is the Founders Professor of the Division of Urology at the University of Pennsylvania School of Medicine, Director of the Residency Program in Urology at the University of Pennsylvania. He is a graduate of Princeton University and received his MD from the University of Pennsylvania School of Medicine. He completed training in Surgery and Urology at the University of Pennsylvania including a fellowship at the Harrison Department of Surgical Research. He has been certified and recertified (voluntary) by the American Board of Urology. He was awarded an honorary Ph.D. from the University of Patras, Greece in September 2005. He was made an honorary professor of the Federal State Institute of Urology of Russia in 2010.

David R. Staskin, M.D. Dr. Staskin is an associate professor of urology at Tufts University. He held similar positions at New York Presbyterian Hospital-Cornell and Beth Israel Deaconess Medical Center-Harvard. Dr. Staskin has an international reputation in lower urinary tract pharmacology and devices. He has specific expertise in pharmaceuticals used to treat overactive bladder and stress incontinence. He was member of HHS-AHCPR and a Section Chairperson of ICI-WHO. He has held advisory positions with numerous pharmaceutical and medical device companies.